South Africa's health minister on Tuesday called lenacapavir, the first twice-yearly HIV prevention jab in the world, a “groundbreaking” tool to fight the disease, but warned initial donated supply would be limited to nearly half a million people in the African country with the highest prevalence rate.
This comes just weeks after the U.S. announced plans to buy 2 million doses of the HIV prevention drug for low-income countries.
